In a groundbreaking development that could significantly impact the lives of over eight million people globally suffering from Parkinson’s disease, researchers from the University of South Australia have unveiled a new injectable drug that promises to replace the daily pill regimen currently endured by patients. This innovation is particularly relevant to the more than one million Americans grappling with this debilitating neurological disorder…